...
首页> 外文期刊>The journal of immunology >Fractalkine Is an Epithelial and Endothelial Cell-Derived Chemoattractant for Intraepithelial Lymphocytes in the Small Intestinal Mucosa
【24h】

Fractalkine Is an Epithelial and Endothelial Cell-Derived Chemoattractant for Intraepithelial Lymphocytes in the Small Intestinal Mucosa

机译:Fractalkine是上皮和内皮细胞衍生的小肠粘膜上皮内淋巴细胞趋化因子。

获取原文
           

摘要

Fractalkine is a unique chemokine that combines properties of both chemoattractants and adhesion molecules. Fractalkine mRNA expression has been observed in the intestine. However, the role of fractalkine in the healthy intestine and during inflammatory mucosal responses is not known. Studies were undertaken to determine the expression and function of fractalkine and the fractalkine receptor CX3CR1 in the human small intestinal mucosa. We identified intestinal epithelial cells as a novel source of fractalkine. The basal expression of fractalkine mRNA and protein in the intestinal epithelial cell line T-84 was under the control of the inflammatory mediator IL-1β. Fractalkine was shed from intestinal epithelial cell surface upon stimulation with IL-1β. Fractalkine localized with caveolin-1 in detergent-insoluble glycolipid-enriched membrane microdomains in T-84 cells. Cellular distribution of fractalkine was regulated during polarization of T-84 cells. A subpopulation of isolated human intestinal intraepithelial lymphocytes expressed the fractalkine receptor CX3CR1 and migrated specifically along fractalkine gradients after activation with IL-2. Immunohistochemistry demonstrated fractalkine expression in intestinal epithelial cells and endothelial cells in normal small intestine and in active Crohn’s disease mucosa. Furthermore, fractalkine mRNA expression was significantly up-regulated in the intestine during active Crohn’s disease . This study demonstrates that fractalkine-CX3CR1-mediated mechanism may direct lymphocyte chemoattraction and adhesion within the healthy and diseased human small intestinal mucosa.
机译:Fractalkine是一种独特的趋化因子,结合了趋化剂和粘附分子的特性。在肠道中已观察到Fractalkine mRNA表达。然而,尚不知道在健康的肠中以及在炎性粘膜反应过程中,fractalkine的作用。进行了研究以确定人小肠粘膜中fractalkine和fractalkine受体CX3CR1的表达和功能。我们确定肠道上皮细胞为fractalkine的新型来源。肠上皮细胞系T-84中fractalkine mRNA和蛋白的基础表达受炎症介质IL-1β的控制。 IL-1β刺激后,Fractalkine从肠上皮细胞表面脱落。 Fractalkine用小窝蛋白1定位在T-84细胞中不溶于去污剂的富含糖脂的膜微区中。在T-84细胞极化过程中调节了fractalkine的细胞分布。分离的人肠上皮内淋巴细胞的亚群表达了fractalkine受体CX3CR1,并在被IL-2激活后沿fractalkine梯度特异性迁移。免疫组织化学表明,在正常小肠和活动性克罗恩病粘膜中,肠上皮细胞和内皮细胞中的fractalkine表达。此外,在活跃的克罗恩病期间,肠道中的fractalkine mRNA表达明显上调。这项研究表明,fractalkine-CX3CR1介导的机制可能指导健康人和患病小肠粘膜内淋巴细胞的化学吸引和粘附。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号